These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11753645)

  • 1. The HPV-16 E7 oncoprotein binds Skip and suppresses its transcriptional activity.
    Prathapam T; Kühne C; Banks L
    Oncogene; 2001 Nov; 20(52):7677-85. PubMed ID: 11753645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Binding of the human papillomavirus type 16 E7 oncoprotein and the adeno-associated virus Rep78 major regulatory protein in vitro and in yeast and the potential for downstream effects.
    Hermonat PL; Santin AD; Zhan D
    J Hum Virol; 2000; 3(3):113-24. PubMed ID: 10881991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor.
    Maldonado E; Cabrejos ME; Banks L; Allende JE
    J Cell Biochem; 2002; 85(4):663-9. PubMed ID: 11968006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of the HPV E7 proteins with the pCAF acetyltransferase.
    Avvakumov N; Torchia J; Mymryk JS
    Oncogene; 2003 Jun; 22(25):3833-41. PubMed ID: 12813456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ski interacts with the evolutionarily conserved SNW domain of Skip.
    Prathapam T; Kühne C; Hayman M; Banks L
    Nucleic Acids Res; 2001 Sep; 29(17):3469-76. PubMed ID: 11522815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A mutational analysis of the amino terminal domain of the human papillomavirus type 16 E7 oncoprotein.
    Brokaw JL; Yee CL; Münger K
    Virology; 1994 Dec; 205(2):603-7. PubMed ID: 7975265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The E6 protein of human papillomavirus type 16 binds to and inhibits co-activation by CBP and p300.
    Patel D; Huang SM; Baglia LA; McCance DJ
    EMBO J; 1999 Sep; 18(18):5061-72. PubMed ID: 10487758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Ski oncoprotein interacts with Skip, the human homolog of Drosophila Bx42.
    Dahl R; Wani B; Hayman MJ
    Oncogene; 1998 Mar; 16(12):1579-86. PubMed ID: 9569025
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of p53 transcriptional activity by the HPV E7 proteins.
    Massimi P; Banks L
    Virology; 1997 Jan; 227(1):255-9. PubMed ID: 9007083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Destabilization of the retinoblastoma tumor suppressor by human papillomavirus type 16 E7 is not sufficient to overcome cell cycle arrest in human keratinocytes.
    Helt AM; Galloway DA
    J Virol; 2001 Aug; 75(15):6737-47. PubMed ID: 11435552
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of domains required for transcriptional activation and protein dimerization in the human papillomavirus type-16 E7 protein.
    Zwerschke W; Joswig S; Jansen-Dürr P
    Oncogene; 1996 Jan; 12(1):213-20. PubMed ID: 8552395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human papillomavirus E7 oncoprotein abrogates signaling mediated by interferon-alpha.
    Barnard P; McMillan NA
    Virology; 1999 Jul; 259(2):305-13. PubMed ID: 10388655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of E7/Rb associations.
    Caldeira S; Dong W; Tommasino M
    Methods Mol Med; 2005; 119():363-79. PubMed ID: 16350411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300.
    Bernat A; Avvakumov N; Mymryk JS; Banks L
    Oncogene; 2003 Sep; 22(39):7871-81. PubMed ID: 12970734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
    Campo-Fernández B; Morandell D; Santer FR; Zwerschke W; Jansen-Dürr P
    J Virol; 2007 Jan; 81(2):1027-32. PubMed ID: 17093190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral interaction: a possible contributing factor in head and neck cancer progression.
    Underbrink MP; Hoskins SL; Pou AM; Albrecht T
    Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHES1/FOXN3 interacts with Ski-interacting protein and acts as a transcriptional repressor.
    Scott KL; Plon SE
    Gene; 2005 Oct; 359():119-26. PubMed ID: 16102918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells.
    Banks L; Edmonds C; Vousden KH
    Oncogene; 1990 Sep; 5(9):1383-9. PubMed ID: 2216461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of the fork head domain transcription factor MPP2 with the human papilloma virus 16 E7 protein: enhancement of transformation and transactivation.
    Lüscher-Firzlaff JM; Westendorf JM; Zwicker J; Burkhardt H; Henriksson M; Müller R; Pirollet F; Lüscher B
    Oncogene; 1999 Oct; 18(41):5620-30. PubMed ID: 10523841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
    Massimi P; Pim D; Banks L
    J Gen Virol; 1997 Oct; 78 ( Pt 10)():2607-13. PubMed ID: 9349482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.